Volume 20, Number 4—April 2014
Active Surveillance for Avian Influenza Virus, Egypt, 2010–2012
Continuous circulation of influenza A(H5N1) virus among poultry in Egypt has created an epicenter in which the viruses evolve into newer subclades and continue to cause disease in humans. To detect influenza viruses in Egypt, since 2009 we have actively surveyed various regions and poultry production sectors. From August 2010 through January 2013, >11,000 swab samples were collected; 10% were positive by matrix gene reverse transcription PCR. During this period, subtype H9N2 viruses emerged, cocirculated with subtype H5N1 viruses, and frequently co-infected the same avian host. Genetic and antigenic analyses of viruses revealed that influenza A(H5N1) clade 2.2.1 viruses are dominant and that all subtype H9N2 viruses are G1-like. Cocirculation of different subtypes poses concern for potential reassortment. Avian influenza continues to threaten public and animal health in Egypt, and continuous surveillance for avian influenza virus is needed.
In 2008, highly pathogenic avian influenza (HPAI) A(H5N1) virus became enzootic among poultry in Egypt, and the country became an epicenter for virus activity (1). As the established viruses drifted over time, viral genetic and antigenic diversity was generated. During 2010–2011, subclade 2.2.1 viruses (direct-drift progeny of the initially introduced virus) and 220.127.116.11 viruses (which might have emerged because of vaccine pressure) were cocirculating among poultry in Egypt (2). These subclades differed genetically and antigenically, hence complicating control efforts, especially vaccination (3). Subclade 2.2.1 viruses, commonly isolated from backyard flocks that are not vaccinated, caused all of the human cases in Egypt; from 2006 through September 2013, the toll rose to 173 cases and 63 deaths (4,5). Subclade 18.104.22.168 viruses were more prevalent on commercial farms, where vaccines are more frequently used (6). Furthermore, recent reports have indicated that very few mutations are needed for subtype H5N1 to become transmissible among ferrets, the best mammalian model of human influenza infection (7,8). In Egypt, a subtype H5N1 virus was found to have 2 of the 4 mutations needed to gain the transmissibility function, thereby underlying the need and urgency for surveillance among poultry (8). The Nile Delta region of Egypt was also identified as an area where substantial reassortment of influenza viruses can take place (9). As a further complication, in 2011, subtype H9N2 viruses were detected in poultry from areas in Egypt where subtype H5N1 viruses circulate (10).
Since 2009, we have been conducting systematic, active surveillance of avian influenza virus (AIV) among poultry in Egypt; the same locations are sampled over time, regardless of whether a clinical outbreak of disease is present. We previously reported that the threat of HPAI (H5N1) virus is widespread beyond rural areas and that the commercial sector is a key reservoir for virus transmission (11). Here we provide an update on the changing epizootiology and genetic features of AIV in Egypt and report co-infection of poultry in Egypt with influenza virus subtypes H5N1 and H9N2.
Sample Collection and Processing
A team of veterinarians collected cloacal and oropharyngeal swab samples from 11,452 birds from 4 poultry production sectors: commercial farms, backyard flocks, live-bird markets, and abattoirs. One swab sample was collected per bird, and depending on the size of the population, as many as 5 birds were sampled per flock. Birds were not randomly selected; samples were also collected from sick or dead birds found on site. From August 2010 through January 2013, a total of 6,904 cloacal and 4,548 oropharyngeal samples were collected from 63 sites in 7 governorates in Egypt, including Cairo (4 neighborhoods); 4 Nile Delta governorates (Qalubiya [12 villages], Menofiya [9 villages], Sharqiya [3 towns], and Daqahliya [4 towns]); and 2 mid-Egypt governorates (Fayyoum [22 villages] and BeniSuef [9 villages]) (Figure 1). The selected governorates represent the main foci of the poultry industry in Egypt and sites of previous AIV detection (11). The selected sampling sites were areas at which the veterinarian was known to the local population and thus had access to the poultry. The sites were routinely visited on a monthly basis regardless of the occurrence of clinical signs or poultry deaths. Study veterinarians subjectively recorded their field observations. Swab samples were collected in medium containing 50% glycerol, 50% phosphate-buffered saline (PBS), penicillin (2 × 106 U/L), streptomycin (200 mg/L), and amphotericin B (250 mg/L) (antimicrobial drugs from Lonza, Walkersville, MD, USA). Samples were chilled on ice until delivered to the laboratory (within 24 hours). All samples were stored at –80°C until used.
Screening for AIV
For detection of AIV, 100 µL from 5 samples was pooled; RNA extracted from pools collected up to July 2012 was subjected to reverse transcription PCR (RT-PCR) to amplify 244 bp of the matrix segment of AIV, according to World Health Organization (WHO) protocol (12). Samples with amplified M segments were subjected to H5, H7, and H9 hemagglutinin subtype determination by RT-PCR according to the same WHO protocol, except the annealing temperature for H5 primers was 58°C (12,13). As of August 2012, quantitative RT-PCR (qRT-PCR) was used for typing and subtyping AIV. Typing and subtyping primers are listed in Table 1.
Samples that showed a positive reaction in the partial M segment RT-PCR were grown in the allantoic cavities of 10-day-old specific pathogen–free embryonated chicken eggs. Virus titers were determined by chicken red blood cell hemagglutination assays (12).
Hemagglutinin Gene Sequencing and Sequence Analyses
The purified amplicons of 26 H5 and 15 H9 segments, selected to represent time and species, were sequenced as described (15). Phylogenetic analyses were performed by using MEGA version 4.0.2 (www.megasoftware.net) with the neighbor-joining method and Poisson correction (16). The sequences were submitted to GenBank under accession nos. KF258174–91, CY099582–8, CY099591–3, JX912982–6, JX912988, JX912990–2, and JX912994–7.
Chicken red blood cell hemagglutination inhibition (HI) assays were conducted in accordance with the WHO protocol (12) and with monoclonal antibodies against influenza virus subtype H5N1. Antigenic maps were constructed by using virus titers and AntigenMap software (17).
Influenza Virus Subtype H5N1 and H9N2 Co-infection
Because co-infection with influenza virus subtypes H5N1 and H9N2 can give way to viral reassortment and production of viral progeny with unpredictable phenotypes, we studied co-infected samples in more detail. The presence of the 2 viruses in 3 selected samples collected in 2012 (Q5018B, D5809C, D5809D) was detected by RT-PCR, qRT-PCR, hemagglutinin sequence analysis, immunofluorescence, and Western blotting. The samples were propagated in specific pathogen–free embryonated chicken eggs, and the allantoic fluid was subjected to qRT-PCR. To separate the 2 viruses, we then conducted a plaque purification assay. Individual plaques were picked and injected into specific pathogen–free embryonated chicken eggs and MDCK cells (in the presence or absence of L-1-tosylamide-2-phenylethyl chloromethyl ketone [TPCK]–treated trypsin). After incubation, the allantoic fluids and cell culture supernatant were harvested and subjected to qRT-PCR.
A 100-μL sample of the original decontaminated samples and 10-fold serial dilutions from each sample were inoculated into wells of a 6-well plate containing confluent MDCK cells with 400 μL serum-free medium. The plates were incubated at 37°C for 1 hour. The wells were aspirated to remove residual viral solution. Each well was then immediately covered with 2 mL 1× agarose overlay mixture (final concentration 1% agarose type 1, 1× Dulbecco modified Eagle medium, 10% antibiotic/antimycotic solution). Plates were then incubated at 37°C under 5% CO2 for 2 days. Plaques were picked, and each plaque was inoculated into specific pathogen–free embryonated chicken eggs for propagation of purified plaques.
MDCK cells were inoculated with original co-infected specimens. At 1 day after inoculation, the cells were fixed with 1 mL 3.7% formalin in PBS for 5 min, and then 1 mL cold methanol was added for 5 min. Cells were blocked by using 1 mL 1% bovine serum albumin (Serva, Heidelberg, Germany) in PBS-Tween 20 at 37°C for 1 hour. Rat and chicken antiserum against H5N1 and H9N2 viruses, respectively, were incubated with the fixed cells. Fluorescein isothiocyanate–conjugated goat anti–chicken IgG and goat anti–rat IgG diluted 1:2000 (KPL, Gaithersburg, MD, USA) were then added. Fluorescently labeled cells were examined by using fluorescence microscopy.
Viruses propagated in specific pathogen–free embryonated chicken eggs were analyzed by SDS PAGE (sodium dodecyl sulfate polyacrylamide gel electrophoresis) as described (18); the only modification was that 1% bovine serum albumin in PBS–0.3% Tween20 was used to block the protein-free binding sites on the nitrocellulose membrane. Immunorecognition was performed on cut membrane strips carrying chicken anti-H9N2 serum (dilution 1:50) or mouse anti-H5 monoclonal antibody (dilution 1:100). Immune detection was conducted by using peroxidase-conjugated goat anti–chicken IgG and goat anti–mouse IgG (KPL) diluted 1:2000 in PBS–0.3% Tween20.
Equal titers of influenza virus subtypes H5N1 and H9N2 were separately or jointly inoculated into specific pathogen–free embryonated chicken eggs and MDCK cells. The amount of virus propagated was measured by qRT-PCR at 24 hours after inoculation.
The proportion of samples that were positive according to the different study variables was determined. The Pearson χ2 test was used
AIV in Poultry
Test results were positive for 1,144 birds (Table 2); the overall percentage of AIV detected was 10% (95% CI 9.5%–10.5%). This percentage differed significantly according to governorate, species, production sector, health status, and age (Table 2). The detection percentage by governorate ranged from 3% in Menofiya to 18% in Daqahliya (Figure 1). Detection percentage for urban Cairo was 6.4%. Of the swab samples collected, 84.2% were from chickens, 10.3% were from ducks, and 5.5% were from other species of domestic birds (Table 2). The detection percentage was highest among turkeys (15.3%); followed by ducks (12.3%); and then chickens, pigeons, and geese (≈9%). Among swab samples collected from the different poultry sectors, the highest percentage positive for AIV (≈12%) came from commercial farms and backyard flocks, followed by live-bird markets (6.7%) and abattoirs (5.1%). Most (88.3%) swab samples were collected from apparently healthy birds; of those, 8.3% were positive for AIV. Influenza A viruses were detected in 20.8% of sick and 42.4% of dead birds. The detection percentage among poultry >1 year of age was 19.4%; that among birds <1 year of age was 9.9%.
More AIV was detected in poultry during colder months, and none was detected in August (Figure 2; Technical Appendix [PDF - 461 KB - 5 pages] Figure). Among poultry, the detection percentage for AIV was <5% until September 2012, when we recorded a sudden increase of >15%. This outbreak peaked at ≈25% in October 2012 and continued into January 2013 (Figure 2). This outbreak was detected at all of our sampling sites and was more pronounced in Cairo, Fayyoum, and BeniSuef, where we did not detect AIV before this outbreak (Technical Appendix [PDF - 461 KB - 5 pages] Figure 1).
Of the 1,144 influenza virus–positive samples, we subtyped 897. From August 2010 through November 2011, all 59 AIV samples were subtype H5N1. Figure 3 shows the percentage of each subtype identified from December 2011 through January 2013. In December 2011, we detected the first subtype H9N2 virus in our surveillance program. In March 2012, we detected the first subtype H5N1 and H9N2 co-infections. We then detected 151 incidences of co-infection throughout the reporting period. During the September 2012–January 2013 outbreak, detection of AIV increased dramatically; thus, we randomly selected positive samples from that period for subtyping. During September–November 2012, subtype H5N1 and co-infections constituted most (92%) subtypes detected. In December 2012, detection of subtype H5N1 decreased. Overall, subtype H5N1 was the dominant subtype by governorate, species, production sector, health status, and age (Table 3). Throughout this period, we isolated 112 viruses in specific pathogen–free embryonated chicken eggs.
We constructed a phylogenetic tree of the hemagglutinin gene of influenza A(H5N1) viruses from Egypt (Figure 4). Clade 2.2 viruses circulated during 2006–2007 and were distinct from those that prevailed during 2008–2009, when the virus was declared enzootic. Clades 2.2.1 and 22.214.171.124 viruses cocirculated from 2010 through mid-2011. Clade 126.96.36.199 then receded, and all viruses isolated from late 2011 through 2013 were from clade 2.2.1. The subtype H5N1 virus sequence obtained from samples that were co-infected with subtype H9N2 virus did not differ from the sequences of clade 2.2.1 viruses. However, 1 subtype H5N1 virus from a co-infected sample (A/chicken/Egypt/Q5013B/2012) clustered with the extinct clade 2.2 viruses. No other virus from recent years has had a similar sequence.
Phylogenetic analysis of the hemagglutinin gene of subtype H9N2 viruses that reemerged in Egypt in 2011 indicated that only viruses with a G1-like lineage circulated among poultry in Egypt (Figure 5). Influenza A(H9N2) viruses from Egypt clustered together, thus showing minor evolution during the past 2 years. Sequences obtained from samples co-infected with subtype H5N1 also showed no significant differences from the sequences of subtype H9N2 viruses that were not from co-infected samples.
Antigenic Characterization of Influenza A(H5N1) Viruses
Results of HI assay of the 2012–2013 viruses conducted against a panel of monoclonal antibodies were used to update a previously published antigenic cartograph (3). Our results indicate that antigenically, subtype H5N1 viruses from Egypt have drifted over time; in 2010, two clusters of viruses (clades 2.2.1 and 188.8.131.52) cocirculated. In 2011–2013, clade 2.2.1 viruses dominated (Technical Appendix [PDF - 461 KB - 5 pages] Figure 2).
Clinical Signs, 2006–2013
We previously reported our field observations of illness and death caused by HPAI viruses in poultry in Egypt (19). Briefly, during 2006–2007, when clade 2.2 viruses were circulating, mortality rates were up to 100%. During 2008–2009, when the virus became enzootic, mortality rates dropped to 30%–40%. Here we show that in 2010, when viruses from clades 2.2.1 and 184.108.40.206 cocirculated, mortality rates were 20%–60%, and this trend continued into 2011. Subsequently, the commercial farms we surveyed decreased their vaccine use. By 2012, as clade 220.127.116.11 viruses receded, mortality rates started to increase. Samples that indicated co-infection with subtypes H5N1 and H9N2 came from flocks that were killed because of the infection. Furthermore, the September 2012 outbreak was caused by viruses that caused high mortality rates among commercial and backyard flocks. In fact, most (96%) influenza-positive samples that were collected from sick or dead poultry were collected during this outbreak.
The presence of influenza virus subtypes H5N1 and H9N2 in the 3 selected samples was confirmed by RT-PCR, qRT-PCR, hemagglutinin sequence analysis, immunofluorescence, and Western blotting (Technical Appendix [PDF - 461 KB - 5 pages] Figure 3). In egg culture, subtype H9 virus grew faster than did subtype H5 after 1 passage in eggs, although the cycle thresholds for both viruses were the same for the original swab sample (Technical Appendix [PDF - 461 KB - 5 pages] Figure 4). To separate the 2 viruses, we then conducted a plaque purification assay. All plaques that were individually picked from the plaque assay and propagated on egg or cell culture were subtype H9N2 viruses.
To understand our inability to isolate subtype H5N1 virus by plaque purification, we conducted an experimental co-infection analysis of both viruses at an equal dose of 100 PFU/mL in MDCK cells and in specific pathogen–free embryonated chicken eggs. Our results showed that 24 hours after inoculation, both viruses grew to similar titers in MDCK cells in the presence of TPCK-treated trypsin, and the presence of the other virus in the culture did not affect propagation (Technical Appendix [PDF - 461 KB - 5 pages] Figure 5). In eggs, subtype H9N2 virus grew more efficiently than did subtype H5N1 virus, but the presence of the other virus did not affect the propagation rate of either virus (Technical Appendix [PDF - 461 KB - 5 pages] Figure 5).
AIV subtypes H5N1 and H9N2 were very common among domestic poultry in Egypt. The highest percentage of AIV detected was among turkeys and ducks that appeared to be healthy. Ducks in Egypt, like those in other regions, play a key role in AIV transmission (20).We also detected AIV in chickens in all sectors of production. Virus detection among pigeons sampled at markets and abattoirs was 8.8%, but no viruses were isolated from these birds. Therefore, pigeons might have become incidental carriers while coming in contact with other infected poultry in live-bird markets at which all the pigeons included in our surveillance were swabbed. Percentage of AIV detection was high (≈12%) at commercial farms and backyard flocks, where chickens, ducks, geese, and turkeys were sampled. In our previous analysis of surveillance data obtained from August 2009 through July 2010, the commercial farm sector was a more common reservoir of AIV than was the backyard sector (11). The continuous evolution of the virus and the disappearance of clade 18.104.22.168 viruses that predominantly circulated on commercial farms might explain the findings in our current analysis. AIV detection rates at abattoirs in Cairo and live-bird markets at different sites were ≈6%. This finding suggests that the threat of bird-to-human transmission might extend beyond the backyard setting, where most cases of subtype H5 infection in humans in Egypt were reported. Our previous analysis had the same result (11). Influenza virus infection in apparently health poultry increased from 4.5% in the previous period to 8.3%. This finding might be caused by subtype H9N2 virus infections that are mainly asymptomatic in poultry.
During our surveillance period, influenza A(H5N1) virus infections among humans occurred in a seasonal pattern that peaked during February and March (Figure 2). These cases in humans occurred mostly during months when influenza activity was detected in poultry. Globally, most humans with influenza A(H5N1) virus infection reported having had contact with sick or dead poultry (21). The decrease in the number of cases in humans in late 2012, when infections in poultry increased, remains unexplained, although this decrease occurred at a time when human cases usually peak. The political situation during this period might have affected case detection and reporting.
Previous studies have documented the presence of other influenza virus subtypes in migratory birds in Egypt, although none have reported isolating those subtypes from domestic poultry (22–24). In contrast, subtype H9N2 viruses have been detected in domestic poultry in several neighboring Middle Eastern countries (25–29). As of May 2011, subtype H9N2 viruses were detected on quail and chicken farms in Egypt by another group (10), and in December 2011, they were detected by our surveillance. However, how influenza virus subtype H9N2 was introduced into Egypt remains unclear.
Using RT-PCR, we detected a substantial rate of co-infection with influenza virus subtypes H9N2 and H5N1. This cocirculation and co-infection of multiple influenza viruses increases the chances of subtype H5N1 virus reassortment. Our phylogenetic and antigenic analyses of subtype H5N1 viruses indicated that clade 22.214.171.124 viruses receded and that 2.2.1 viruses are widely circulating. The emergence and recession of clade 126.96.36.199 viruses warrants further investigation of the role that vaccine use plays in emergence of variants. During September 2012–January 2013, increased detection (as much as 24%) of clade 2.2.1 virus infection was noticed. These viruses were associated with high mortality rates and were responsible for the September 2012 outbreak. Furthermore, this shift from the <5% that was detected before that time was substantial. Subtype H9N2 viruses might have played a role in this increased spread and severity through an unknown mechanism. However, subtype H9N2 virus did not mask infection with subtype H5N1 virus, as previously suggested (30). Yet in co-infected samples, subtype H9N2 might be more easily detected, especially if culture or serologic assays were used, because our data indicate that subtype H9N2 virus grows faster than subtype H5N1 virus in co-infected field samples. Subtype H9N2 virus was circulating in neighboring Middle Eastern countries since at least 2000 but was not detected in Egypt until May 2011; therefore, we hypothesized that subtype H9N2 virus emerged when the pathogenicity of subtype H5N1 virus decreased. Accordingly, we repeated our co-infection experiments with subtype H5N1 viruses isolated annually during 2006–2011. The results were similar to the subtype H9N2/H5N1 virus co-infections in 2012, showing that varying subtype H5N1 virus pathogenicity over time was not a factor in the emergence of subtype H9N2 virus in Egypt (data not shown). Factors that led to the emergence of subtype H9N2 virus and the consequences of its co-infection with subtype H5N1 virus remain unclear.
Through our systematic surveillance program of AIV in poultry in Egypt, we were able to detect 3 major events: emergence of subtype H9N2 virus, co-infection of single hosts with subtypes H9N2 and H5N1 viruses, and increased detection of AIV as of September 2012. We determined that the reservoir for AIV is not localized to a specific sector of poultry production in Egypt, is not specific to a single species, and is geographically widespread. Although our findings indicate that cocirculation and co-infection with AIVs are low, these events are of major concern because of their high potential for reassortment, which can lead to virus progeny with novel characteristics that threaten not only avian health but also human health.
Our study had several limitations. First, our surveillance did not include all geographic areas, and southern Egypt was not adequately represented. The climate in southern Egypt differs from that in the Delta, and the presence of the Aswan Dam and Nasser Reservoir might affect the epizootiology of influenza viruses given the presence of wild bird species. Furthermore, we did not sample any wild or migratory birds, thus limiting our findings, especially those associated with the emergence of subtype H9N2 virus. In areas where we conducted our surveillance, we did not randomly select sites; rather, we sampled sites that were accessible to our veterinarians. Although the possibility is small, given our sampling scheme, selection bias might have occurred.
Our findings showed that influenza viruses continue to threaten animal and human health in Egypt. In the poultry industry, HPAI A(H5N1) viruses usually lead to major economic losses. Subtype H9N2 viruses, although of low pathogenicity, are correlated with increased severity because of co-infection with other poultry viruses; thus, they indirectly might lead to economic losses for the industry. On the public health side, our findings that AIVs are widespread throughout poultry sectors and geographic regions indicate that a large segment of the population of Egypt is at risk. Subtype H9N2 viruses also infect humans, thereby adding to the risk for infection with subtype H5N1 virus. Our results can be used to better focus and target animal health and public health policy in Egypt. Indeed, Egypt remains an epicenter for AIV circulation, and vigilant surveillance remains the single-most effective tool for keeping track of these viruses.
Dr Kayali is a postdoctoral research associate at the St. Jude Children’s Research Hospital, Memphis, Tennessee. His research interests are the epidemiology of influenza and viral zoonotic diseases.
This work was funded by the US Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, under contract no. HHSN266200700005C, and supported by the American Lebanese Syrian Associated Charities.
- WHO/OIE/FAO H5N1 Evolution Working Group. Continuing progress towards a unified nomenclature for the highly pathogenic H5N1 avian influenza viruses: divergence of clade 2.2 viruses. Influenza Other Respir Viruses. 2009;3:59–62.
- WHO/OIE/FAO H5N1 Evolution Working Group. Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature. Influenza Other Respir Viruses. 2012;6:1–5.
- El-Shesheny R, Kayali G, Kandeil A, Cai Z, Barakat AB, Ghanim H, Antigenic diversity and cross-reactivity of avian influenza H5N1 viruses in Egypt between 2006 and 2011. J Gen Virol. 2012;93:2564–74.
- World Health Organization. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003–2013 [cited 2013 Apr 15]; http://www.who.int/influenza/human_animal_interface/EN_GIP_20130426CumulativeNumberH5N1cases.pdf
- Younan M, Poh MK, Elassal E, Davis T, Rivailler P, Balish AL, Microevolution of highly pathogenic avian influenza A(H5N1) viruses isolated from humans, Egypt, 2007–2011. Emerg Infect Dis. 2013;19:43–50.
- Arafa A, Suarez DL, Hassan MK, Aly MM. Phylogenetic analysis of hemagglutinin and neuraminidase genes of highly pathogenic avian influenza H5N1 Egyptian strains isolated from 2006 to 2008 indicates heterogeneity with multiple distinct sublineages. Avian Dis. 2010;54(Suppl):345–9.
- Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Airborne transmission of influenza A/H5N1 virus between ferrets. Science. 2012;336:1534–41 .
- Imai H, Shinya K, Takano R, Kiso M, Muramoto Y, Sakabe S, The HA and NS genes of human H5N1 influenza A virus contribute to high virulence in ferrets. PLoS Pathog. 2010;6:e1001106.
- Fuller TL, Gilbert M, Martin V, Cappelle J, Hosseini P, Njabo KY, Predicting hotspots for influenza virus reassortment. Emerg Infect Dis. 2013;19:581–8.
- Arafa AS, Hagag N, Erfan A, Mady W, El-Husseiny M, Adel A, Complete genome characterization of avian influenza virus subtype H9N2 from a commercial quail flock in Egypt. Virus Genes. 2012;45:283–94.
- Kayali G, El-Shesheny R, Kutkat MA, Kandeil AM, Mostafa A, Ducatez MF, Continuing threat of influenza (H5N1) virus circulation in Egypt. Emerg Infect Dis. 2011;17:2306–8.
- World Health Organization. WHO manual on animal influenza diagnosis and surveillance. 2nd ed. 2002 [cited 2011 Dec 12]. http://whqlibdoc.who.int/hq/2002/WHO_CDS_CSR_NCS_2002.5.pdf
- Lee MS, Chang PC, Shien JH, Cheng MC, Shieh HK. Identification and subtyping of avian influenza viruses by reverse transcription-PCR. J Virol Methods. 2001;97:13–22.
- Centers for Disease Control and Prevention. CDC realtime RTPCR protocol for detection and characterization of influenza. Atlanta: the Centers; 2007.
- Shanmuganatham K, Feeroz MM, Jones-Engel L, Smith GJ, Fourment M, Walker D, Antigenic and molecular characterization of avian influenza A(H9N2) viruses, Bangladesh. Emerg Infect Dis. 2013;19:1393–402.
- Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007;24:1596–9.
- Cai Z, Zhang T, Wan XF. A computational framework for influenza antigenic cartography. PLOS Comput Biol. 2010;6:e1000949.
- Ruppel A, Diesfeld HJ, Rother U. Immunoblot analysis of Schistosoma mansoni antigens with sera of schistosomiasis patients: diagnostic potential of an adult schistosome polypeptide. Clin Exp Immunol. 1985;62:499–506 .
- Kayali G, Webby RJ, Ducatez MF, El Shesheny RA, Kandeil AM, Govorkova EA, The epidemiological and molecular aspects of influenza H5N1 viruses at the human–animal interface in Egypt. PLoS ONE. 2011;6:e17730.
- Kim JK, Negovetich NJ, Forrest HL, Webster RG. Ducks: the “Trojan horses” of H5N1 influenza. Influenza Other Respir Viruses. 2009;3:121–8.
- Uyeki TM. Global epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses. Respirology. 2008;13(Suppl 1):S2–9 .
- Aly MM, Arafa A, Kilany WH, Sleim AA, Hassan MK. Isolation of a low pathogenic avian influenza virus (H7N7) from a black kite (Milvus migrans) in Egypt in 2005. Avian Dis. 2010;54(Suppl):457–60.
- Amin A, Shalaby MA, Imam IZ. Studies on influenza virus isolated from migrating birds in Egypt. Comp Immunol Microbiol Infect Dis. 1980;3:241–6.
- Soliman A, Saad M, Elassal E, Amir E, Plathonoff C, Bahgat V, Surveillance of avian influenza viruses in migratory birds in Egypt, 2003–09. J Wildl Dis. 2012;48:669–75 and.
- Aamir UB, Wernery U, Ilyushina N, Webster RG. Characterization of avian H9N2 influenza viruses from United Arab Emirates 2000 to 2003. Virology. 2007;361:45–55.
- Brown IH, Banks J, Manvell RJ, Essen SC, Shell W, Slomka M, Recent epidemiology and ecology of influenza A viruses in avian species in Europe and the Middle East. Dev Biol (Basel). 2006;124:45–50 .
- Moosakhani F, Shoshtari AH, Pourbakhsh SA, Keyvanfar H, Ghorbani A. Phylogenetic analysis of the hemagglutinin genes of 12 H9N2 influenza viruses isolated from chickens in Iran from 2003 to 2005. Avian Dis. 2010;54:870–4.
- Perk S, Banet-Noach C, Shihmanter E, Pokamunski S, Pirak M, Lipkind M, Genetic characterization of the H9N2 influenza viruses circulated in the poultry population in Israel. Comp Immunol Microbiol Infect Dis. 2006;29:207–23.
- Roussan DA, Khawaldeh GY, Al Rifai RH, Totanji WS, Shaheen IA. Avian influenza virus H9 subtype in poultry flocks in Jordan. Prev Vet Med. 2009;88:77–81.
- Khalenkov A, Perk S, Panshin A, Golender N, Webster RG. Modulation of the severity of highly pathogenic H5N1 influenza in chickens previously inoculated with Israeli H9N2 influenza viruses. Virology. 2009;383:32–8 and.
Suggested citation for this article: Kayali G, Kandeil A, El-Shesheny R, Kayed AS, Gomaa MM, Maatouq AM, et al. Active surveillance for avian influenza virus, Egypt, 2010–2012. Emerg Infect Dis [Internet]. 2014 Apr [date cited]. http://dx.doi.org/10.3201/eid2004.131295
- Page created: March 12, 2014
- Page last updated: March 12, 2014
- Page last reviewed: March 12, 2014
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)